data_1tns_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tns _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ttt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.479 -0.563 . . . . 3.4 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.3 133.86 34.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.259 -0.9 . . . . 2.86 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.1 tp -161.65 74.35 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 1.23 109.289 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -81.73 160.78 23.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.37 109.033 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.8 t -135.23 155.15 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.419 -0.801 . . . . 1.17 109.559 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -101.04 153.09 37.94 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.383 -0.823 . . . . 0.89 109.144 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.61 -44.04 52.56 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 121.278 1.319 . . . . 0.23 110.481 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -58.95 -26.4 64.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.163 -0.961 . . . . 2.65 109.913 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 11.0 mm-40 -84.33 -23.61 30.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.055 -1.028 . . . . 2.06 109.489 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.528 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.8 mt -81.8 -21.14 37.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 1.05 108.956 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 1.08 111.04 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.528 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.3 m120 -146.05 -8.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.554 -1.341 . . . . 2.94 110.828 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 18.2 mt -78.98 147.11 69.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.621 -1.3 . . . . 1.07 108.095 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.03 -66.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.071 1.181 . . . . 0.29 110.817 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.61 -36.07 3.23 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.432 -1.067 . . . . 0.22 110.432 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 24.9 mt -94.91 149.5 36.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.158 -1.201 . . . . 1.06 109.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.06 177.69 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.885 1.057 . . . . 0.21 109.837 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -97.98 7.67 45.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.285 -0.885 . . . . 2.66 109.733 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -132.87 129.95 39.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 1.08 109.369 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 p -52.36 -30.68 29.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 1.63 109.482 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -38.69 64.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 1.08 109.386 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.37 -35.08 34.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.445 -1.462 . . . . 0.24 109.445 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.9 t -65.89 -54.69 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 1.03 109.427 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -58.32 -44.51 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 1.1 109.017 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -60.67 -42.89 97.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.023 -1.048 . . . . 1.04 108.848 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.1 -22.14 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.491 -0.756 . . . . 1.12 109.086 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.76 -30.96 67.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.218 -0.926 . . . . 1.07 108.751 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.429 ' C ' ' H ' ' A' ' 30' ' ' GLN . 18.3 mtpp -71.41 -29.3 64.74 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.792 -0.818 . . . . 2.95 108.792 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -65.09 -2.54 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 2.83 109.13 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.429 ' H ' ' C ' ' A' ' 28' ' ' LYS . 41.5 mt-30 -150.16 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.339 -0.851 . . . . 1.39 108.878 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.97 48.94 2.56 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.113 -1.195 . . . . 0.28 110.113 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -48.52 139.33 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.271 . . . . 0.29 109.232 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -47.88 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 2.51 109.428 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' TRP . 6.3 p30 -102.97 119.74 39.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.431 -0.793 . . . . 1.95 109.639 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.576 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -87.1 128.66 35.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.165 -0.959 . . . . 3.66 109.168 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.69 152.44 20.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.957 -1.089 . . . . 1.61 108.924 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -148.89 84.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.417 -0.802 . . . . 4.25 108.962 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.24 54.58 0.71 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 2.15 109.611 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 1.1 1.5 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.967 -1.253 . . . . 2.21 109.967 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.08 -83.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.111 -1.229 . . . . 3.03 108.707 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -80.52 -74.06 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 5.09 109.227 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.59 72.16 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.561 -1.416 . . . . 3.0 109.561 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 44' ' ' LYS . . . 161.72 46.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.913 -1.275 . . . . 2.2 109.913 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 43' ' ' GLY . 32.4 mtmm 52.05 97.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -1.162 . . . . 3.8 109.365 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.67 127.72 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.476 -0.765 . . . . 1.34 109.329 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 61.3 mt -87.4 150.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.319 -0.863 . . . . 1.91 109.815 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.2 mt-10 -140.03 170.41 15.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.494 -0.928 . . . . 2.21 108.494 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -136.19 129.74 32.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 0.97 109.569 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -75.76 120.77 21.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 1.44 109.048 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.44 -32.37 57.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.338 -0.852 . . . . 1.09 109.991 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -70.34 -19.29 63.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 2.86 109.563 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -88.97 -23.04 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.91 . . . . 0.94 109.672 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.78 148.44 98.5 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 1.09 108.896 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.25 -165.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.837 1.025 . . . . 0.45 109.686 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.4 -37.93 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.252 -0.905 . . . . 1.08 109.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -59.03 -39.07 80.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 2.23 109.592 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.01 -36.74 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 1.02 109.436 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -61.8 -64.06 1.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 2.16 109.217 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.31 -43.79 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 1.18 109.378 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.5 77.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 1.1 109.262 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.8 -61.41 2.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.84 109.02 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -48.79 -25.09 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 1.88 109.488 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.7 tp -69.0 -54.82 13.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 2.37 109.628 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 10.7 ptm180 -75.42 8.06 3.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.955 . . . . 2.97 110.281 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -88.9 -11.6 44.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.956 -1.09 . . . . 2.84 109.329 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.33 114.94 2.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.579 -1.408 . . . . 2.85 109.579 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 55.99 93.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -1.167 . . . . 6.11 109.382 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.14 -77.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 5.31 109.442 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -136.18 -133.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.494 -0.754 . . . . 7.34 108.984 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.576 ' HG1' ' H ' ' A' ' 71' ' ' SER . 8.6 t -80.73 -139.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.936 -1.103 . . . . 7.5 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.576 ' H ' ' HG1' ' A' ' 70' ' ' THR . 0.9 OUTLIER 73.33 -74.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 7.66 109.562 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.44 28.56 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.215 -0.928 . . . . 6.81 109.28 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.38 -18.3 2.29 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 8.65 109.668 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' O ' ' CG ' ' A' ' 75' ' ' PHE . 23.4 m-85 -83.75 25.89 0.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 11.53 109.353 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 74' ' ' TYR . 44.1 p90 40.84 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.738 -0.601 . . . . 12.19 110.206 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 74' ' ' TYR . 1.9 tm-20 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 9.64 109.453 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ttt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.479 -0.563 . . . . 3.0099999999999998 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.3 133.86 34.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.259 -0.9 . . . . 2.8599999999999999 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.1 tp -161.65 74.35 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.56000000000000005 109.289 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -81.73 160.78 23.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.31 109.033 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.8 t -135.23 155.15 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.419 -0.801 . . . . 0.81000000000000005 109.559 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -101.04 153.09 37.94 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.383 -0.823 . . . . 0.27000000000000002 109.144 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.61 -44.04 52.56 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 121.278 1.319 . . . . 0.19 110.481 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -58.95 -26.4 64.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.163 -0.961 . . . . 2.1699999999999999 109.913 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 11.0 mm-40 -84.33 -23.61 30.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.055 -1.028 . . . . 2.0600000000000001 109.489 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.8 mt -81.8 -21.14 37.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.20999999999999999 108.956 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.19 111.04 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.3 m120 -146.05 -8.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.554 -1.341 . . . . 2.1699999999999999 110.828 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 18.2 mt -78.98 147.11 69.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.621 -1.3 . . . . 0.22 108.095 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.03 -66.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.071 1.181 . . . . 0.27000000000000002 110.817 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.61 -36.07 3.23 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.432 -1.067 . . . . 0.20999999999999999 110.432 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 24.9 mt -94.91 149.5 36.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.158 -1.201 . . . . 0.22 109.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.06 177.69 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.885 1.057 . . . . 0.20000000000000001 109.837 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -97.98 7.67 45.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.285 -0.885 . . . . 2.1699999999999999 109.733 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -132.87 129.95 39.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 0.26000000000000001 109.369 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 p -52.36 -30.68 29.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 1.2 109.482 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -38.69 64.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.34000000000000002 109.386 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.37 -35.08 34.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.445 -1.462 . . . . 0.17000000000000001 109.445 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.9 t -65.89 -54.69 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.26000000000000001 109.427 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -58.32 -44.51 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.29999999999999999 109.017 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -60.67 -42.89 97.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.023 -1.048 . . . . 0.70999999999999996 108.848 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.1 -22.14 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.491 -0.756 . . . . 0.34000000000000002 109.086 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.76 -30.96 67.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.218 -0.926 . . . . 0.28000000000000003 108.751 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -71.41 -29.3 64.74 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.792 -0.818 . . . . 2.3700000000000001 108.792 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -65.09 -2.54 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 2.4199999999999999 109.13 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.16 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.339 -0.851 . . . . 1.3899999999999999 108.878 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.97 48.94 2.56 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.113 -1.195 . . . . 0.23999999999999999 110.113 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -48.52 139.33 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.271 . . . . 0.25 109.232 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -47.88 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 2.1099999999999999 109.428 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' O ' ' ND2' ' A' ' 34' ' ' ASN . 0.4 OUTLIER -102.97 119.74 39.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.431 -0.793 . . . . 1.1499999999999999 109.639 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -87.1 128.66 35.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.165 -0.959 . . . . 3.0899999999999999 109.168 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.69 152.44 20.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.957 -1.089 . . . . 1.21 108.924 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -148.89 84.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.417 -0.802 . . . . 3.6699999999999999 108.962 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.24 54.58 0.71 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 1.77 109.611 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 1.1 1.5 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.967 -1.253 . . . . 2.21 109.967 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.08 -83.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.111 -1.229 . . . . 2.5699999999999998 108.707 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' H ' HG23 ' A' ' 40' ' ' VAL . 77.3 tttt -80.52 -74.06 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 4.7400000000000002 109.227 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.59 72.16 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.561 -1.416 . . . . 2.3900000000000001 109.561 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 44' ' ' LYS . . . 161.72 46.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.913 -1.275 . . . . 2.2000000000000002 109.913 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 43' ' ' GLY . 32.4 mtmm 52.05 97.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -1.162 . . . . 3.2999999999999998 109.365 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.67 127.72 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.476 -0.765 . . . . 1.1299999999999999 109.329 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 61.3 mt -87.4 150.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 109.815 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.2 mt-10 -140.03 170.41 15.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.494 -0.928 . . . . 2.21 108.494 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -136.19 129.74 32.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 0.34999999999999998 109.569 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -75.76 120.77 21.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.95999999999999996 109.048 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.44 -32.37 57.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.338 -0.852 . . . . 0.28000000000000003 109.991 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -70.34 -19.29 63.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 2.21 109.563 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -88.97 -23.04 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.91 . . . . 0.34999999999999998 109.672 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.78 148.44 98.5 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.29999999999999999 108.896 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.25 -165.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.837 1.025 . . . . 0.45000000000000001 109.686 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.4 -37.93 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.252 -0.905 . . . . 0.34000000000000002 109.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -59.03 -39.07 80.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 2.23 109.592 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.01 -36.74 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.26000000000000001 109.436 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -61.8 -64.06 1.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 1.6699999999999999 109.217 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.31 -43.79 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.42999999999999999 109.378 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.5 77.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 109.262 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.8 -61.41 2.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.22 109.02 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -48.79 -25.09 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 1.29 109.488 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.7 tp -69.0 -54.82 13.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 1.72 109.628 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 10.7 ptm180 -75.42 8.06 3.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.955 . . . . 2.5299999999999998 110.281 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -88.9 -11.6 44.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.956 -1.09 . . . . 2.3399999999999999 109.329 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.33 114.94 2.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.579 -1.408 . . . . 2.8500000000000001 109.579 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 55.99 93.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -1.167 . . . . 6.1100000000000003 109.382 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.14 -77.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 5.0999999999999996 109.442 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -136.18 -133.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.494 -0.754 . . . . 7.3399999999999999 108.984 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.527 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 8.6 t -80.73 -139.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.936 -1.103 . . . . 7.2000000000000002 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.429 ' N ' HG23 ' A' ' 70' ' ' THR . 0.9 OUTLIER 73.33 -74.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 7.3499999999999996 109.562 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -94.44 28.56 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.215 -0.928 . . . . 6.8099999999999996 109.28 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.38 -18.3 2.29 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 8.6500000000000004 109.668 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' O ' ' CG ' ' A' ' 75' ' ' PHE . 23.4 m-85 -83.75 25.89 0.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 11.15 109.353 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 74' ' ' TYR . 44.1 p90 40.84 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.738 -0.601 . . . . 11.5 110.206 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 74' ' ' TYR . 1.9 tm-20 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 9.6400000000000006 109.453 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 ttt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.479 -0.563 . . . . 3.01 109.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -89.3 133.86 34.3 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.259 -0.9 . . . . 2.86 109.463 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 25.1 tp -161.65 74.35 0.45 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.91 . . . . 0.56 109.289 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 57.4 m95 -81.73 160.78 23.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 0.31 109.033 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.8 t -135.23 155.15 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.419 -0.801 . . . . 0.81 109.559 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.4 m -101.04 153.09 37.94 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.383 -0.823 . . . . 0.27 109.144 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -53.61 -44.04 52.56 Favored 'Trans proline' 0 C--N 1.325 -0.702 0 C-N-CA 121.278 1.319 . . . . 0.19 110.481 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.8 pttt -58.95 -26.4 64.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.163 -0.961 . . . . 2.17 109.913 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.524 ' O ' ' NH1' ' A' ' 64' ' ' ARG . 11.0 mm-40 -84.33 -23.61 30.15 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.055 -1.028 . . . . 2.06 109.489 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.496 ' C ' ' H ' ' A' ' 12' ' ' ASN . 95.8 mt -81.8 -21.14 37.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.21 108.956 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 29.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.617 -0.677 . . . . 0.19 111.04 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.496 ' H ' ' C ' ' A' ' 10' ' ' LEU . 26.3 m120 -146.05 -8.49 0.54 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.554 -1.341 . . . . 2.17 110.828 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 16' ' ' LEU . 18.2 mt -78.98 147.11 69.46 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 120.621 -1.3 . . . . 0.22 108.095 179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -59.03 -66.16 0.07 OUTLIER 'Trans proline' 0 C--N 1.323 -0.766 0 C-N-CA 121.071 1.181 . . . . 0.27 110.817 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -43.61 -36.07 3.23 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.432 -1.067 . . . . 0.21 110.432 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 13' ' ' LEU . 24.9 mt -94.91 149.5 36.41 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.158 -1.201 . . . . 0.22 109.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -55.06 177.69 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.789 0 C-N-CA 120.885 1.057 . . . . 0.2 109.837 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -97.98 7.67 45.96 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.285 -0.885 . . . . 2.17 109.733 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -132.87 129.95 39.09 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.455 -0.778 . . . . 0.26 109.369 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 5.1 p -52.36 -30.68 29.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 1.2 109.482 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.84 -38.69 64.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.34 109.386 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -78.37 -35.08 34.38 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.445 -1.462 . . . . 0.17 109.445 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 27' ' ' ALA . 34.9 t -65.89 -54.69 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -1.152 . . . . 0.26 109.427 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 19.4 mt -58.32 -44.51 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.244 -0.91 . . . . 0.3 109.017 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -60.67 -42.89 97.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.023 -1.048 . . . . 0.71 108.848 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.3 t -75.1 -22.14 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.491 -0.756 . . . . 0.34 109.086 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -58.76 -30.96 67.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.218 -0.926 . . . . 0.28 108.751 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -71.41 -29.3 64.74 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.792 -0.818 . . . . 2.37 108.792 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.7 tttp -65.09 -2.54 2.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.384 -0.823 . . . . 2.42 109.13 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -150.16 -61.74 0.2 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.339 -0.851 . . . . 1.39 108.878 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 93.97 48.94 2.56 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.113 -1.195 . . . . 0.24 110.113 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' ASN . 3.7 m-90 -48.52 139.33 9.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.271 . . . . 0.25 109.232 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -47.88 98.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.155 -0.966 . . . . 2.11 109.428 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' TRP . 6.3 p30 -102.97 119.74 39.38 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.431 -0.793 . . . . 1.15 109.639 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.589 HH11 ' CG ' ' A' ' 35' ' ' ARG . 0.3 OUTLIER -87.1 128.66 35.11 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.165 -0.959 . . . . 3.09 109.168 179.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.69 152.44 20.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.957 -1.089 . . . . 1.21 108.924 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 tpt180 -148.89 84.03 1.46 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.417 -0.802 . . . . 3.67 108.962 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.24 54.58 0.71 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 1.77 109.611 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.75 1.1 1.5 Allowed Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.967 -1.253 . . . . 2.21 109.967 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.475 HG23 ' H ' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -93.08 -83.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.111 -1.229 . . . . 2.57 108.707 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' H ' HG23 ' A' ' 40' ' ' VAL . 77.3 tttt -80.52 -74.06 0.33 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 4.74 109.227 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 154.59 72.16 0.01 OUTLIER Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.561 -1.416 . . . . 2.39 109.561 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 44' ' ' LYS . . . 161.72 46.48 0.02 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.913 -1.275 . . . . 2.2 109.913 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 43' ' ' GLY . 32.4 mtmm 52.05 97.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.225 -1.162 . . . . 3.3 109.365 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.67 127.72 35.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.476 -0.765 . . . . 1.13 109.329 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 61.3 mt -87.4 150.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.319 -0.863 . . . . 1.42 109.815 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.403 ' O ' ' CB ' ' A' ' 34' ' ' ASN . 36.2 mt-10 -140.03 170.41 15.91 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 108.494 -0.928 . . . . 2.21 108.494 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -136.19 129.74 32.11 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.353 -0.842 . . . . 0.35 109.569 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -75.76 120.77 21.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 0.96 109.048 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.44 -32.37 57.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.338 -0.852 . . . . 0.28 109.991 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 33.9 m-20 -70.34 -19.29 63.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 2.21 109.563 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.7 m -88.97 -23.04 22.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.245 -0.91 . . . . 0.35 109.672 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.78 148.44 98.5 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.097 -1.002 . . . . 0.3 108.896 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -57.25 -165.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.325 -0.683 0 C-N-CA 120.837 1.025 . . . . 0.45 109.686 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.8 t -88.4 -37.93 10.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.252 -0.905 . . . . 0.34 109.479 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -59.03 -39.07 80.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.299 -0.876 . . . . 2.23 109.592 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.01 -36.74 30.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.25 -0.906 . . . . 0.26 109.436 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -61.8 -64.06 1.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 1.67 109.217 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -48.31 -43.79 33.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.43 109.378 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -67.12 -34.5 77.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.28 109.262 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 11.2 tp -63.8 -61.41 2.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.22 109.02 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -48.79 -25.09 1.66 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.215 -0.928 . . . . 1.29 109.488 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.7 tp -69.0 -54.82 13.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 1.72 109.628 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.524 ' NH1' ' O ' ' A' ' 9' ' ' GLU . 10.7 ptm180 -75.42 8.06 3.1 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.171 -0.955 . . . . 2.53 110.281 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 27.7 mm-40 -88.9 -11.6 44.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.956 -1.09 . . . . 2.34 109.329 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -48.33 114.94 2.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.579 -1.408 . . . . 2.85 109.579 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 55.99 93.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.216 -1.167 . . . . 6.11 109.382 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 38.9 mt -85.14 -77.92 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.235 -0.916 . . . . 5.1 109.442 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' A' ' 70' ' ' THR . 0.0 OUTLIER -136.18 -133.64 0.15 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.494 -0.754 . . . . 7.34 108.984 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.527 ' H ' ' CD ' ' A' ' 69' ' ' GLU . 8.6 t -80.73 -139.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.936 -1.103 . . . . 7.2 109.365 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.429 ' N ' HG23 ' A' ' 70' ' ' THR . 0.9 OUTLIER 73.33 -74.16 0.09 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.222 -0.924 . . . . 7.35 109.562 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.443 ' C ' HD12 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -94.44 28.56 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.215 -0.928 . . . . 6.81 109.28 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -50.38 -18.3 2.29 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.668 -1.373 . . . . 8.65 109.668 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.531 ' O ' ' CG ' ' A' ' 75' ' ' PHE . 23.4 m-85 -83.75 25.89 0.75 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.168 -1.195 . . . . 11.15 109.353 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 74' ' ' TYR . 44.1 p90 40.84 23.6 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.738 -0.601 . . . . 11.5 110.206 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 74' ' ' TYR . 1.9 tm-20 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.298 -0.876 . . . . 9.64 109.453 179.771 . . . . . . . . 1 1 . 1 stop_ save_